Circulation, Vol 86, 1376-1382, Copyright © 1992 by American Heart Association
JT Hii, DG Wyse, AM Gillis, HJ Duff, MA Solylo and LB Mitchell
BACKGROUND. Patients with a history of class Ia drug-induced torsade de
pointes have been treated with chronic amiodarone without recurrence of
torsade de pointes despite comparable prolongation of the QT interval. We
hypothesized that in such patients, class Ia drugs cause nonhomogeneous
prolongation of cardiac repolarization times, whereas amiodarone causes
homogeneous prolongation of cardiac repolarization times. METHODS AND
RESULTS. Thirty-eight consecutive patients who received both class Ia drug
therapy and chronic amiodarone therapy were evaluated. Standard 12-lead
ECGs at baseline and during each therapy were used to calculate precordial
QT interval dispersion (maximum QT in leads V1 through V6 minus minimum QT
leads V1 through V6) as a measure of regional variabilities in ventricular
repolarization times. Nine of these patients had torsade de pointes during
class Ia drug therapy. In these nine patients, class Ia drug therapy and
amiodarone significantly prolonged the maximum QT interval to comparable
extents. However, class Ia drug therapy but not amiodarone therapy
significantly increased precordial QT interval dispersion (101 +/- 37
versus 49 +/- 26 msec; baseline, 44 +/- 12 msec; p = 0.002). In the 29
patients without class Ia drug-induced torsade de pointes, neither class Ia
drug therapy nor amiodarone therapy significantly increased QT interval
dispersion (50 +/- 6 versus 69 +/- 7 msec; baseline, 54 +/- 5 msec). None
of the patients with class Ia drug-induced torsade de pointes had recurrent
torsade de pointes during chronic amiodarone therapy. CONCLUSIONS. An
increase in regional QT interval dispersion during class Ia antiarrhythmic
drug therapy is associated with torsade de pointes. Chronic amiodarone
therapy in patients with a history of class Ia drug- induced torsade de
pointes produces comparable maximum QT interval prolongation but does not
increase QT interval dispersion. This characteristic may explain its
apparent safe use in patients with a history of class Ia drug-induced
torsade de pointes.
ARTICLES
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone
Department of Medicine, Foothills Medical Centre, Calgary, Alberta, Canada.
This article has been cited by other articles:
 |
|
 |
|
  E. Shantsila, T. Watson, and G. Y. Lip Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias Europace, September 1, 2007; 9(suppl_4): iv37 - iv44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ueda, T. Hayashi, K. Tsumura, K. Yoshimaru, Y. Nakayama, and J. Yoshikawa Intravenous Nicorandil Can Reduce QT Dispersion and Prevent Bradyarrhythmia During Percutaneous Transluminal Coronary Angioplasty of the Right Coronary Artery Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 179 - 184. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Oztop, M. Gencer, T. Okan, A. Yaren, E. Altekin, S. Turker, and U. Yilmaz Evaluation of Cardiotoxicity of a Combined Bolus plus Infusional 5-Fluorouracil/Folinic Acid Treatment by Echocardiography, Plasma Troponin I Level, QT Interval and Dispersion in Patients with Gastrointestinal System Cancers Jpn. J. Clin. Oncol., May 1, 2004; 34(5): 262 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Antzelevitch, L. Belardinelli, L. Wu, H. Fraser, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, R. J. Goodrow Jr, et al. Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S65 - S83. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Afsar, A. S. Fak, J. T. Metzger, G. Van Melle, L. Kappenberger, and J. Bogousslavsky Acute Stroke Increases QT Dispersion in Patients Without Known Cardiac Diseases Arch Neurol, March 1, 2003; 60(3): 346 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. H.T. Wehrens, M. A. Vos, P. A. Doevendans, and H. J.J. Wellens Novel Insights in the Congenital Long QT Syndrome Ann Intern Med, December 17, 2002; 137(12): 981 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Biffi, G Boriani, M Bartolotti, L Bacchi Reggiani, R Zannoli, and A Branzi Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters Heart, May 1, 2002; 87(5): 443 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Gbadebo, R. W. Trimble, M. S.C. Khoo, J. Temple, D. M. Roden, and M. E. Anderson Calmodulin Inhibitor W-7 Unmasks a Novel Electrocardiographic Parameter That Predicts Initiation of Torsade de Pointes Circulation, February 12, 2002; 105(6): 770 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sawada, M. Hirai, M. Akahoshi, Y. Inden, Y. Yoshida, D. Ishihara, K. Yamada, Y. Takada, T. Tanaka, Y. Takada, et al. Ventricular activation and recovery measured in electrocardiographic limb leads correlate with measurements from specific areas in body surface mapping Europace, January 1, 2002; 4(4): 401 - 410. [Abstract] [PDF]
|
|
|
|
 |
|
 M.-D. Drici Influence of gender on drug-acquired long QT syndrome Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K41 - K47. [Abstract] [PDF]
|
|
|
|
 |
|
 S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]
|
|
|
|
 |
|
 E. Yetkin, K. Senen, M. Ileri, R. Atak, S. Topaloglu, K. Ergun, A. Yanik, I. Tandogan, S. Cehreli, E. Duru, et al. Diurnal Variation of QT Dispersion in Patients With and Without Coronary Artery Disease Angiology, May 1, 2001; 52(5): 311 - 316. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Chevalier, C. Rodriguez, L. Bontemps, M. Miquel, G. Kirkorian, R. Rousson, F. Potet, J.-J. Schott, I. Baro, and P. Touboul Non-invasive testing of acquired long QT syndrome: Evidence for multiple arrhythmogenic substrates Cardiovasc Res, May 1, 2001; 50(2): 386 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kosar, I. Hisar, T. Durmaz, M. Ileri, and I. Tandogan QTc Dispersion Measurement for Risk of Syncope in Patients with Aortic Stenosis Angiology, April 1, 2001; 52(4): 259 - 265. [Abstract] [PDF]
|
|
|
|
|
|
A. D. Demir, M. Soylu, H. Tikiz, U. K. Tezcan, Y. Balbay, and E. Kutuk Polymorphic Ventricular Tachycardia Due to Renal Artery Stenosis: A Case Report Angiology, December 1, 2000; 51(12): 1039 - 1043. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Malik and V. N. Batchvarov Measurement, interpretation and clinical potential of QT dispersion J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1749 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zabel, M. R. Franz, T. Klingenheben, B. Mansion, H.-P. Schultheiss, and S. H. Hohnloser Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testing J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1654 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zabel, B. Acar, T. Klingenheben, M. R. Franz, S. H. Hohnloser, and M. Malik Analysis of 12-Lead T-Wave Morphology for Risk Stratification After Myocardial Infarction Circulation, September 12, 2000; 102(11): 1252 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Gillis, H. J. Mathison, E. Kulisz, and W. M. Lester Dispersion of Ventricular Repolarization and Ventricular Fibrillation in Left Ventricular Hypertrophy: Influence of Selective Potassium Channel Blockers J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 381 - 386. [Abstract] [Full Text]
|
|
|
|
|
|
B. Houltz, B. Darpo, K. Swedberg, P. Blomstrom, H.J.G.M. Crijns, S.M. Jensen, E. Svernhage, and N. Edvardsson Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization Europace, January 1, 2000; 2(1): 20 - 31. [Abstract] [PDF]
|
|
|
|
|
|
K.S. Spargias, S.J. Lindsay, G.I. Kawar, D.C. Greenwood, J.C. Cowan, S.G. Ball, and A.S. Hall QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure Eur. Heart J., August 2, 1999; 20(16): 1158 - 1165. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Kors, G. van Herpen, and J. H. van Bemmel QT Dispersion as an Attribute of T-Loop Morphology Circulation, March 23, 1999; 99(11): 1458 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Paventi, U. Bevilacqua, M. A. Parafati, E. Di Luzio, F. Rossi, P. R. Pelliccioni, and S. Paventi QT Dispersion and Early Arrhythmic Risk During Acute Myocardial Infarction Angiology, March 1, 1999; 50(3): 209 - 215. [Abstract] [PDF]
|
|
|
|
|
|
L. J. L. M. Jordaens The clinical value of QTdispersion: new perspectives on the assessment of cardiac repolarization more than 75 years after Bazett's formula Europace, January 1, 1999; 1(2): 73 - 76. [PDF]
|
|
|
|
|
|
Y Gang, X-h Guo, R Crook, K Hnatkova, A J Camm, and M Malik Computerised measurements of QT dispersion in healthy subjects Heart, November 1, 1998; 80(5): 459 - 466. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. G. Guntheroth, P. S. Spiers, D. R. Dancey, D. A. Redelmeier, E. Rosenthal, T. D. Scholz, A. Yoldi, F. Sena, L. Gutierrez, P. J. Schwartz, et al. Prolongation of the QT Interval and the Sudden Infant Death Syndrome N. Engl. J. Med., October 15, 1998; 339(16): 1161 - 1163. [Full Text]
|
|
|
|
|
|
M. Zabel, T. Klingenheben, M. R. Franz, and S. H. Hohnloser Assessment of QT Dispersion for Prediction of Mortality or Arrhythmic Events After Myocardial Infarction : Results of a Prospective, Long-term Follow-up Study Circulation, June 30, 1998; 97(25): 2543 - 2550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. de Bruyne, A. W. Hoes, J. A. Kors, A. Hofman, J. H. van Bemmel, and D. E. Grobbee QTc Dispersion Predicts Cardiac Mortality in the Elderly : The Rotterdam Study Circulation, February 10, 1998; 97(5): 467 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Grace and A. J. Camm Quinidine N. Engl. J. Med., January 1, 1998; 338(1): 35 - 45. [Full Text] [PDF]
|
|
|
|
|
|
G. Cui, P. T. Sager, B. N. Singh, and L. Sen Different Effects of Amiodarone and Quinidine on the Homogeneity of Myocardial Refractoriness in Patients With Intraventricular Conduction Delay Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(3): 201 - 207. [Abstract] [PDF]
|
|
|
|
|
|
L. De Ambroggi, E. Aime, C. Ceriotti, M. Rovida, and S. Negroni Mapping of Ventricular Repolarization Potentials in Patients With Arrhythmogenic Right Ventricular Dysplasia : Principal Component Analysis of the ST-T Waves Circulation, December 16, 1997; 96(12): 4314 - 4318. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Choy, C. C. Lang, D. M. Chomsky, G. H. Rayos, J. R. Wilson, and D. M. Roden Normalization of Acquired QT Prolongation in Humans by Intravenous Potassium Circulation, October 7, 1997; 96(7): 2149 - 2154. [Abstract] [Full Text]
|
|
|
|
|
|
M Zaidi, A Robert, R Fesler, C Derwael, and C Brohet Dispersion of ventricular repolarisation: a marker of ventricular arrhythmias in patients with previous myocardial infarction Heart, October 1, 1997; 78(4): 371 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.C. Verduyn, M.A. Vos, J. van der Zande, F.F. van der Hulst, and H.J. Wellens Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium Cardiovasc Res, June 1, 1997; 34(3): 453 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Roden, R. Lazzara, M. Rosen, P. J. Schwartz, J. Towbin, and G. M. Vincent Multiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions Circulation, October 15, 1996; 94(8): 1996 - 2012. [Abstract] [Full Text]
|
|
|
|
|
|
J.-L. Demolis, C. Funck-Brentano, J. Ropers, M. Ghadanfar, D. J. Nichols, and P. Jaillon Influence of Dofetilide on QT-Interval Duration and Dispersion at Various Heart Rates During Exercise in Humans Circulation, October 1, 1996; 94(7): 1592 - 1599. [Abstract] [Full Text]
|
|
|
|
|
|
A. van de Loo, T. Klingenheben, and S. H. Hohnloser Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of QT Dispersion to Predict Proarrhythmia Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1996; 1(1): 75 - 78. [Abstract] [PDF]
|
|
|
|
|
|
M. R. Ujhelyi, M. Schur, T. Frede, M. Gabel, and M. L. Markel Differential Effects of Lidocaine on Defibrillation Threshold With Monophasic Versus Biphasic Shock Waveforms Circulation, September 15, 1995; 92(6): 1644 - 1650. [Abstract] [Full Text]
|
|